U.S. Markets close in 1 hr 29 mins

SPDR S&P Health Care Equipment ETF (XHE)

NYSEArca - Nasdaq Real Time Price. Currency in USD
Add to watchlist
62.01-0.49 (-0.78%)
As of 2:05PM EDT. Market open.
People also watch
Full screen
Previous Close62.50
Bid61.90 x 200
Ask62.11 x 1400
Day's Range61.75 - 62.28
52 Week Range46.31 - 63.33
Avg. Volume12,400
Net Assets147.49M
PE Ratio (TTM)N/A
YTD Return23.34%
Beta (3y)0.82
Expense Ratio (net)0.35%
Inception Date2011-01-26
Trade prices are not sourced from all markets
  • Barrons.com19 days ago

    Who Will Win A $6 Billion Lung Caner Biopsy Opportunity?

    Among cancers, lung cancer is the deadliest worldwide, largely because of late diagnoses. Morgan Stanley’s David Lewis and his team write that new tools can disrupt the $6 billion lung biopsy market with better precision and diagnostic accuracy—and that a new system developed via a joint venture between Intuitive Surgical (ISRG) and Fosun International (656.Hong Kong), might be just that tool. Lewis writes that currently, lung biopsy methods have low yields and carry risks, which delays diagnosis and treatment, but that the FC system—a robotic controlled biopsy system using 3D imaging technology to target potential tumors—is more accurate and comes with fewer side effects, which could lower lung cancer mortality.

  • Yahoo Finance25 days ago

    Why $475,000 isn't actually that expensive for Novartis's new drug

    The price tag on Novartis' new cancer drug may be a bargain

  • Yahoo Finance26 days ago

    Trump can lower U.S. drug prices by fixing NAFTA

    Without intellectual property, there is no innovation—and as we’re rapidly discovering, no customers.